Read More Pharma Industry News Janssen Pharmaceutical’s DARZALEX FASPRO gains FDA approval for AL amyloidosis treatment Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has secured FDA approval for DARZALEX FASPRO (daratumumab and hyaluronidase-fihj),… bypharmanewsdailyJanuary 16, 2021
